Recently, nuclear FAK was reported to regulate immunomodulatory functions and inhibit anti-tumor immunity in cancerous squamous epithelial cells by regulating chemokine/cytokine and ligand receptor networks [36], which is consistent with our results. The gene discussed is PTK2; the disease is neoplasm.